Skip to content
Head to head

ResMed vs Intuitive Surgical

Side-by-side on the measures that matter, with a plain-English read. Full detail: RMD · ISRG

Updated moments ago

1-year performance, rebased to 100

RMD -2.7%ISRG -27.0%
ResMed edges it on the scoreable measures. ResMed has the highest Quant Rating (36); ResMed has done best over the past year (-2%); ResMed trades cheapest on trailing earnings.
RMDISRG
Snapshot
SectorMedical Instruments & Supplies--
Last price235.63399.05
Change today-0.53%-2.01%
1-year return-2.3%-27.7%
Market cap$33.14B$138.33B
52-week range179.25 – 274.65328.57 – 603.88
Valuation
P/E (TTM)21.4648.25
P/E percentile, own 5-yr range7th16th
P/B5.578.65
Dividend yield1.04%0.00%
Profitability & growth
EPS (TTM)10.437.87
Net profit (TTM)$1.47B$2.73B
Revenue (TTM)$5.73B$11.58B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+5.9%+21.7%
Gross margin61.1%67.2%
Operating margin33.4%32.3%
Net margin27.8%25.5%
Free cash flow (TTM)$1.59B$3.60B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership76.3%86.7%
Insider activity (12mo)13 buy / 37 sell17 buy / 33 sell
Short interest (% of float)7.4%2.0%
Analyst consensus50% buy / 50% hold (8)100% buy (18)
Analyst price target$274 (+16%)$516 (+29%)
StockVane view
StockVane Quant RatingC (36)E (15)
Company
Employees11,37017,021
Founded19891995

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.